Mass High school Idera Pharmaceuticals Announces installation of Treatment in state of matter 2 Clinical ... MarketWatch (press release) "With the initiation of a state of matter 2 trial for IMO-3100 in psoriasis , we have achieved another of import milestone by having mid-stage clinical trials underway for proprietary drug candidates targeting TLRs in both medical specialty and autoimmune diseases, ... Idera starts Phase ii trial of psoriasis drug Mass High Tech each 14 news articles » Link To Article
No comments:
Post a Comment